New Valeant Pharmaceuticals CEO got almost $63M US in compensation

Valeant Pharmaceuticals says its chairman and CEO received $62.7 million US in compensation for eight months of work last year, even as the Quebec-based drug giant reported a 'disappointing' financial performance.